Bas Oldenburg

Full Professor

Strategic program(s):

Contact

boldenbu@umcutrecht.nl

Pure profile

Research groups

Inflammatory bowel diseases

Research aim

Our research is focused on the elucidation of the pathogenesis of Inflammatory bowel diseases (IBD), personalized medicine and on a severe complication of IBD: colitis-associated colorectal carcinoma.

Go to group

Molecular and cellular host-microbiota interactions

Research aim

Our research aims to unravel how the products from pathogenic and beneficial bacterial species within the intestinal microbiota contribute to human health and disease.

Go to group

Tissue immunology

Research aim

Our mission is to comprehensively understand, monitor, and target immune-mediated inflammatory diseases such as IBD, AD and systemic autoimmune diseases. We aim to unravel (tissue) immune dysregulation and induce long-lasting disease modification.

Go to group

Recent publications

All publications

Next-generation IgA-SEQ allows for high-throughput, anaerobic, and metagenomic assessment of IgA-coated bacteria Merel van Gogh, Jonas M Louwers, Anna Celli, Sanne Gräve, Marco C Viveen, Sofie Bosch, Nanne K H de Boer, Rik J Verheijden, Karijn P M Suijkerbuijk, Eelco C Brand, Janetta Top, Bas Oldenburg, Marcel R de Zoete
Microbiome, 2024, vol. 12

Postoperative outcomes of surgical delay in inflammatory bowel disease patients Ellen de Bock, Eline S Herman, Vincent Meij, Thijs A Burghgraef, Bas Oldenburg, Paul M Verheijen, Apollo Pronk, Mando D Filipe, Menno R Vriens, Milan C Richir
Updates in Surgery, 2024, vol. 76, p.1271-1277

Highly multiplexed spatial analysis identifies tissue-resident memory T cells as drivers of ulcerative and immune checkpoint inhibitor colitis Mick J.M. van Eijs, José J.M. ter Linde, Matthijs J.D. Baars, Mojtaba Amini, Miangela M. Laclé, Eelco C. Brand, Eveline M. Delemarre, Julia Drylewicz, Stefan Nierkens, Rik J. Verheijden, Bas Oldenburg, Yvonne Vercoulen, Karijn P.M. Suijkerbuijk, Femke van Wijk
iScience, 2023, vol. 26

Potential of Mesalazine Therapeutic Drug Monitoring by Measuring Fecal Excretion in Patients With Ulcerative Colitis Maartje M van de Meeberg, Elwin R Verheij, Herma H Fidder, Gerd Bouma, Alwin D R Huitema, Bas Oldenburg
Therapeutic drug monitoring, 2023, vol. 45, p.668-675

Dietary index based on the Food Standards Agency nutrient profiling system and risk of Crohn's disease and ulcerative colitis Antoine Meyer, Catherine Dong, Simon S M Chan, Mathilde Touvier, Chantal Julia, Inge Huybrechts, Geneviève Nicolas, Bas Oldenburg, Alicia K Heath, Tammy Y N Tong, Timothy J Key, Anne Tjønneland, Cecilie Kyrø, Rudolf Kaaks, Verena A Katzke, Manuela M Bergman, Domenico Palli, Giovanna Masala, Rosario Tumino, Carlotta Sacerdote, Sandra M Colorado-Yohar, Maria-Jose Sánchez, Marcela Guevara, Olof Grip, Johanna Holmgren, Amanda Cross, Pontus Karling, Johan Hultdin, Neil Murphy, Mélanie Deschasaux-Tanguy, Serge Hercberg, Pilar Galan, Yahya Mahamat-Saleh, Aurélien Amiot, Marc J Gunter, Marie-Christine Boutron-Ruault, Franck Carbonnel
Alimentary Pharmacology & Therapeutics, 2023, vol. 59, p.558-568

Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease J. E. Kreijne, R. L. Goetgebuer, N. S. Erler, N. K. De Boer, A. G. Siebers, G. Dijkstra, F. A. van Kemenade, F. Hoentjen, B. Oldenburg, A. E. van der Meulen, C. I.J. Ponsioen, M. J. Pierik, C. J. van der Woude, A. C. de Vries,
Alimentary Pharmacology and Therapeutics, 2023, vol. 58, p.207-217